Friday, December 12, 2025

Featuring Michael Yeaman, PhD, MSc, University of California, Los Angeles

Session entitled “Emerging Tolerization Technologies & Clinical Trials” is designed to update knowledge on the fundamental aspects of immune tolerance and loss of immune tolerance in cases of NMOSD or related autoimmune disease. The discussion will feature comparative technologies being developed to restore immune tolerance and the clinical trial landscape for evaluation of these emerging technologies in NMOSD.

Educational Objectives:
After completing this activity, learners will be able to:
1. Describe fundamental aspects of immune tolerance and its mechanisms.
2. Differentiate comparative technologies emerging for NMOSD tolerization.
3. Navigate the current clinical trial landscape for NMOSD tolerization.